View in EDS

59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).

Saved in:
Bibliographic Details
Title: 59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).
Authors: Knox, J.1 (AUTHOR), McNamara, M.G.2 (AUTHOR), Goyal, L.3 (AUTHOR), Cosgrove, D.4 (AUTHOR), Springfeld, C.5 (AUTHOR), Sjoquist, K.6 (AUTHOR), Park, J.O.7 (AUTHOR), Verdaguer, H.8 (AUTHOR), Braconi, C.9 (AUTHOR), Ross, P.10 (AUTHOR), Oh, D-Y.11 (AUTHOR), De Gramont, A.12 (AUTHOR), Shroff, R.T.13 (AUTHOR), Zalcberg, J.R.14 (AUTHOR), Palmer, D.15 (AUTHOR), Valle, J.W.2 (AUTHOR)
Source: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS381-S381. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152688686
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Knox%2C+J%2E%22">Knox, J.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McNamara%2C+M%2EG%2E%22">McNamara, M.G.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goyal%2C+L%2E%22">Goyal, L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cosgrove%2C+D%2E%22">Cosgrove, D.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Springfeld%2C+C%2E%22">Springfeld, C.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sjoquist%2C+K%2E%22">Sjoquist, K.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Park%2C+J%2EO%2E%22">Park, J.O.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verdaguer%2C+H%2E%22">Verdaguer, H.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Braconi%2C+C%2E%22">Braconi, C.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ross%2C+P%2E%22">Ross, P.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oh%2C+D-Y%2E%22">Oh, D-Y.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22De+Gramont%2C+A%2E%22">De Gramont, A.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shroff%2C+R%2ET%2E%22">Shroff, R.T.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zalcberg%2C+J%2ER%2E%22">Zalcberg, J.R.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Palmer%2C+D%2E%22">Palmer, D.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Valle%2C+J%2EW%2E%22">Valle, J.W.</searchLink><relatesTo>2</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2021 Supplement 5, Vol. 32, pS381-S381. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152688686
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2021.08.338
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S381
    Titles:
      – TitleFull: 59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Knox, J.
      – PersonEntity:
          Name:
            NameFull: McNamara, M.G.
      – PersonEntity:
          Name:
            NameFull: Goyal, L.
      – PersonEntity:
          Name:
            NameFull: Cosgrove, D.
      – PersonEntity:
          Name:
            NameFull: Springfeld, C.
      – PersonEntity:
          Name:
            NameFull: Sjoquist, K.
      – PersonEntity:
          Name:
            NameFull: Park, J.O.
      – PersonEntity:
          Name:
            NameFull: Verdaguer, H.
      – PersonEntity:
          Name:
            NameFull: Braconi, C.
      – PersonEntity:
          Name:
            NameFull: Ross, P.
      – PersonEntity:
          Name:
            NameFull: Oh, D-Y.
      – PersonEntity:
          Name:
            NameFull: De Gramont, A.
      – PersonEntity:
          Name:
            NameFull: Shroff, R.T.
      – PersonEntity:
          Name:
            NameFull: Zalcberg, J.R.
      – PersonEntity:
          Name:
            NameFull: Palmer, D.
      – PersonEntity:
          Name:
            NameFull: Valle, J.W.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2021 Supplement 5
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 32
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1